Table 3. Multiple logistic regression of diarrheoa cases from four referral hospitals, by selected pathogens, Sydney, Australia, 2007–2010 (n = 301).
Characteristics | Odds ratio | 95% confidence interval | P-value |
---|---|---|---|
Blastocystis spp. | |||
MSM status | 2.3 | 1.0–5.4 | 0.055 |
Co-morbidity surgery | 2.1 | 0.9–4.7 | 0.068 |
Age group (years) (Ref > 75) | |||
< 5 | 0.0 | Undefined | Undefined |
5–12 | 0.0 | Undefined | Undefined |
13–24 | 0.5 | 0.1–5.1 | 0.582 |
25–49 | 3.0 | 0.9–9.9 | 0.070 |
50–75 | 3.1 | 1.0–9.8 | 0.050 |
Dientamoeba fragilis | |||
MSM status | 12.8 | 1.3–130.7 | 0.031 |
Co-morbidity transplant | 10.1 | 0.7–146.2 | 0.089 |
Co-morbidity cancer | 13.8 | 1.6–122.1 | 0.018 |
Clostridium difficile | |||
Age group years (Ref > 75) | |||
< 5 | 0.0 | Undefined | Undefined |
5–12 | 0.0 | Undefined | Undefined |
13–24 | 0.0 | Undefined | Undefined |
25–49 | 0.0 | Undefined | Undefined |
50–75 | 0.8 | 0.4–1.8 | 0.611 |
Gender (Ref = Male) | 0.4 | 0.2–0.9 | 0.031 |
Co-morbidity surgery | 2.2 | 1.1–4.6 | 0.030 |
Co-morbidity HIV | 0.4 | 0.1–1.1 | 0.070 |
Co-morbidity cancer | 0.3 | 0.1–0.9 | 0.030 |
MSM status | 0.3 | 0.1–1.0 | 0.051 |
Antibiotic use/chemotherapy | 6.3 | 3.2–12.2 | < 0.001 |
Chronic GI | 2.4 | 1.1–5.3 | 0.035 |
Suspect food | 0.2 | 0.0–1.5 | 0.113 |
Campylobacter spp. | |||
MSM status | 0.2 | 0.0–0.7 | 0.011 |
Co-morbidity transplant | 7.0 | 1.6–30.6 | 0.010 |
Co-morbidity cancer | 7.5 | 2.1–26.6 | 0.002 |
Antibiotic use/chemotherapy | 0.1 | 0.0–0.2 | < 0.001 |
Age group (years) (Ref > 75) | |||
< 5 | 0.0 | Undefined | Undefined |
5–12 | 0.0 | Undefined | Undefined |
13–24 | 2.5 | 0.8–7.4 | 0.101 |
25–49 | 1.8 | 0.7–4.4 | 0.206 |
50–75 | 0.3 | 0.1–0.9 | 0.038 |
N-T Salmonella spp. | |||
MSM status | 0.2 | 0.0–1.8 | 0.154 |
Co-morbidity surgery | 0.2 | 0.0–1.4 | 0.094 |
Age group (years) (Ref > 75) | |||
< 5 | 0.0 | Undefined | Undefined |
5–12 | 0.0 | Undefined | Undefined |
13–24 | 14.4 | 2.4–85.8 | 0.003 |
25–49 | 3.6 | 0.8–16.9 | 0.102 |
50–75 | 0.7 | 0.1–4.6 | 0.693 |
Gender (Ref = Male) | 7.4 | 2.2–24.8 | 0.001 |
Shigella spp. | |||
MSM status | 5.0 | 1.6–16.0 | 0.007 |
Co-morbidity HIV | 3.3 | 1.0–10.9 | 0.055 |
Suspect food | 3.5 | 1.1–11.2 | 0.037 |
GI, gastrointestinal illness; MSM, men who have sex with men; and Ref, reference group.